If you’re moving from Wegovy (semaglutide for weight loss) or Ozempic (semaglutide, usually for type 2 diabetes) to Mounjaro (tirzepatide), the safest switch is the one that follows two principles:

Do not overlap injections (don’t take semaglutide and tirzepatide together unless a specialist specifically instructs it). Some UK prescribing guidance for weight management explicitly advises not adding tirzepatide to an existing GLP-1 receptor agonist and to seek specialist advice if switching from a GLP-1 RA.
Keep the switch simple: finish your current weekly dose, then start Mounjaro on a clear weekly schedule with a dose you can tolerate.

This guide is written to support a safe patient plan. For product details, dosing options, and how MedCare supplies treatment, see the Mounjaro weight loss injection pen page.

Table of Contents

Can you switch from Wegovy/Ozempic to Mounjaro?

In many cases, yes but it should be Prescriber-led, especially if you have type 2 diabetes, take insulin/sulfonylureas, have significant side effects, or have medical cautions.

Why switching needs care:

Semaglutide stays in the body for weeks because its half-life is about 1 week. Official product information notes semaglutide can remain in circulation for weeks after the last dose.
Tirzepatide’s half-life is ~5 days, which supports weekly dosing but still overlaps in “effect window” if you stack medicines too close together.

That’s why the goal is no overlap and a tolerable start dose.

If you want the full differences (mechanism, expected appetite effects, practical differences that influence switching), use this supporting page: Mounjaro vs Wegovy (key differences that affect switching).

The non-negotiable safety rules (before you switch)

Rule 1: Don’t overlap weekly injections

Avoid taking Wegovy/Ozempic and Mounjaro “together” (same week overlap) unless a specialist has a specific reason and monitoring plan. UK weight management guidance warns against adding tirzepatide to an existing GLP-1 receptor agonist and advises specialist input if switching.

Rule 2: Tell your clinician if you use diabetes medicines

If you take insulin or a sulfonylurea, switching incretin therapy can change glucose control and raise hypoglycaemia risk. (Dose changes must be planned, not sudden.)

Rule 3: If you had severe GI side effects, plan a slower transition

Nausea, vomiting, reflux, constipation and diarrhoea are common during dose escalation on these medicines. A “faster” switch can feel harsher if your stomach is already irritated.

When should you start Mounjaro after your last Wegovy/Ozempic dose?

Because Wegovy and Ozempic are usually once-weekly, the cleanest practical rule is:

Start Mounjaro on your next scheduled weekly injection day

If you normally inject semaglutide every Monday, you would typically plan Mounjaro for the next Monday instead of your semaglutide dose not alongside it.

This keeps your weekly routine stable and avoids stacking doses too close together.

Why this works:

Mounjaro dosing can be resumed weekly, and official guidance allows the weekly day to be changed as long as spacing rules are respected.

If your clinician advises a longer gap due to side effects, that can be appropriate but the default patient-friendly structure is “next scheduled dose day, no overlap.”

What dose do you start on when switching?

Most switching plans begin with a tolerable entry dose and then build using the standard titration schedule. Even if you were on a higher Wegovy/Ozempic dose, it doesn’t automatically mean you should jump into a high Mounjaro dose on week 1.

Practical starting logic (patient-safe)

If you struggled with nausea on semaglutide: start low and go slower.
If you tolerated semaglutide very well: your clinician may choose a faster ramp but only if the risk of side effects is low.

For the exact weekly step-up (2.5mg → upward titration), follow the dosing ladder here:
Mounjaro dosage schedule (weekly titration from 2.5mg to 15mg)

Safe Transition Plan (step-by-step)

Step 1 – Confirm your reason for switching

Common reasons include: limited response, side effects, cost/supply, or clinician preference. Write down your “why” so your clinician can match dose speed to your goal.

Step 2 – Lock your switch date

Pick the next scheduled injection day as your Mounjaro start day (unless a clinician advises waiting longer).

Step 3 – Stop semaglutide (no overlap)

Your last Wegovy/Ozempic injection is your “finish line.” After that:

Do not take another semaglutide dose if Mounjaro is starting.

Step 4 – Start Mounjaro on a tolerable entry dose

Use the entry dose from your prescription, then follow the weekly escalation plan.

Step 5 – Manage side effects proactively (first 2-4 weeks)

Eat smaller meals, slow down fatty meals, and keep hydration consistent.
If nausea is a problem, don’t “push up” dose too fast.

Step 6 – Track the right signals (not just weight)

Monitor:

Appetite and meal tolerance
Bowel habit changes
Hydration status (dizziness, dark urine)
If diabetic: glucose trends

Quick comparison table (switching-relevant details)

Feature	Wegovy	Ozempic	Mounjaro
Active ingredient	Semaglutide	Semaglutide	Tirzepatide
Weekly dosing	Yes	Yes	Yes
Missed-dose window	48 hours rule used in official prescribing info and patient guidance	(Semaglutide product rules vary by label/indication)	Take within 4 days (96 hours) or skip
Half-life (why overlap matters)	~1 week	~1 week (same drug)	~5 days

“What if…” rules during the switch

What if you miss your first Mounjaro dose?

If a Mounjaro dose is missed, official guidance says take it as soon as possible within 4 days; if more than 4 days have passed, skip and take the next dose on your regular day.

What if your switch is delayed by delivery or travel?

Don’t “double up.” Keep the weekly structure. If a gap happens, you may need a clinician to decide whether to restart at a lower step.

What if you still feel strong semaglutide side effects at switch time?

If you’re actively nauseated or vomiting, it’s reasonable to discuss delaying the first Mounjaro dose so you don’t compound GI effects.

Special safety note: contraception (important for switching)

Some professional guidance notes tirzepatide can reduce oral contraceptive bioavailability, so extra contraception precautions may be recommended around initiation and dose increases.
If this applies, your clinician should advise the safest option for you.

When to get urgent medical help

Seek urgent help if you develop:

Severe, persistent abdominal pain (especially with vomiting)
Signs of dehydration you can’t correct (fainting, inability to keep fluids down)
Signs of an allergic reaction (swelling, breathing difficulty)